ALEXANDRIA, Va., April 7 -- United States Patent no. 12,597,496, issued on April 7, was assigned to CLOSED LOOP MEDICINE LTD. (Altrincham, Great Britain).
"Dosing of incretin pathway drugs" was invented by Paul Goldsmith (London), David Bruce Campbell (Dover, Great Britain), Michael Catt (Wellingborough, Great Britain), Tom Godec (London) and Joe Coghlin (London).
According to the abstract* released by the U.S. Patent & Trademark Office: "A computer implemented method for determining a dosage of semaglutide for administering to a patient for the treatment of obesity includes receiving patient data relating to a patient, wherein the patient data includes patient weight data; processing the patient data with a dosage calculator to determine...